ChEM-H is seeking applicants for a tenured or tenure-track faculty position at any level (Assistant, Associate, or Full Professor). Applicants are expected to have an M.D. or M.D./Ph.D. degree and be board certified or eligible in any medical specialty.
The EPFL-Stanford Exchange Program, funded by Firmenich, is now accepting applications from Ph.D. students and faculty for short-term research exchanges.
Applications are now being accepted for the Stanford Interdisciplinary Graduate Fellowship (SIGF) affiliated with Stanford ChEM-H.
Stanley Qi is gaining attention for his work to modify the popular gene-editing enzyme CRISPR. The modified enzyme is a powerful tool to study and modulate gene function with novel therapeutic potential.
Researchers have developed a new way to use atomic force microscopy to rapidly measure the mechanical properties of cells at the nanometer scale, an advance that could pave the way for better understanding immune disorders and cancer.
Jeffrey Glenn will lead a new center to develop new anti-viral therapies that target the host rather than the infection. The center will collaborate with ChEM-H as well as other Stanford institutes.
ChEM-H Director Chaitan Khosla discusses ChEM-H, his goals for the institute and the challenge of bridging the worlds of chemistry and biology.
Lingyin Li to join Stanford ChEM-H as assistant professor of biochemistry
Lei Stanley Qi joined Stanford ChEM-H as assistant professor of bioengineering and of chemical and systems biology
Polly Fordyce joined Stanford ChEM-H as assistant professor of genetics.
Carolyn Bertozzi joined Stanford ChEM-H as professor of chemistry and, by courtesy, of chemical and systems biology.
Peter Kim joined Stanford ChEM-H as professor of biochemistry